Production (Stage)
Claritas Pharmaceuticals, Inc.
CLAZF
$0.00
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.00K | 282.00K | 28.00K | 5.00K | 490.00K |
| Total Receivables | 102.00K | 102.00K | 108.00K | 206.00K | 165.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.58M | 5.43M | 1.05M | 764.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.33M | 5.33M | -- | -- | -- |
| Total Current Assets | 11.02M | 11.15M | 1.18M | 975.00K | 655.00K |
|
|
|||||
| Total Current Assets | 11.02M | 11.15M | 1.18M | 975.00K | 655.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | 1.29M | 1.77M | 1.81M |
| Goodwill | -- | -- | 1.29M | 1.77M | 1.81M |
| Total Other Intangibles | -- | -- | 5.63M | 7.69M | 7.87M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.00K | 8.00K | 5.00K | 6.00K | 546.00K |
| Total Assets | 11.02M | 11.16M | 8.11M | 10.45M | 10.89M |
|
|
|||||
| Total Accounts Payable | 371.00K | 417.00K | 951.00K | 908.00K | 864.00K |
| Total Accrued Expenses | 961.00K | 877.00K | 1.00M | 1.07M | 921.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 538.00K | 542.00K | 406.00K | 925.00K | 826.00K |
| Total Finance Division Other Current Liabilities | 5.86M | 5.86M | 4.28M | 4.22M | 4.17M |
| Total Other Current Liabilities | 5.86M | 5.86M | 4.28M | 4.22M | 4.17M |
| Total Current Liabilities | 7.73M | 7.70M | 6.64M | 7.13M | 6.78M |
|
|
|||||
| Total Current Liabilities | 7.73M | 7.70M | 6.64M | 7.13M | 6.78M |
| Long-Term Debt | -- | -- | -- | -- | 69.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.00K | 694.00K | 1.30M | 1.81M | 1.77M |
| Total Liabilities | 7.74M | 8.39M | 7.93M | 8.94M | 8.62M |
|
|
|||||
| Common Stock & APIC | 62.35M | 62.01M | 57.48M | 56.51M | 56.62M |
| Retained Earnings | -59.07M | -59.25M | -57.31M | -55.01M | -54.35M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.28M | 2.76M | 176.00K | 1.51M | 2.27M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.28M | 2.76M | 176.00K | 1.51M | 2.27M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.28M | 2.76M | 176.00K | 1.51M | 2.27M |
|
|
|||||